(34.204.187.106)
Users online: 2449    [ij] [ij] [ij] 
Email id
 

Research Journal of Pharmacy and Technology
Year : 2020, Volume : 13, Issue : 6
First page : ( 3041) Last page : ( 3044)
Print ISSN : 0974-3618. Online ISSN : 0974-360X.
Article DOI : 10.5958/0974-360X.2020.00537.5

Risk and Opportunities in Development of New Drug

Rajashekar S*, Rajukamaraj, Abimanyu S

Department of Pharmaceutical Regulatory Affairs, SRM College of Pharmacy, SRM Institute of Science and Technology, Kattankulathur-603203, Kanchipuram, Tamilnadu, India

*Corresponding Author E-mail: dakum171@gmail.com

Online published on 4 July, 2020.

Abstract

Drug Regulatory Affairs refers to all aspects within the pharmaceutical process on drug discovery and research which also deals with many risks and opportunities of drug development and they have subject to different degrees of regulations of different countries such as India, USA, Europe. The pharmaceutical law frame is used as guidelines on covering Quality, Safety and Efficacy of a drug as well as Health Authorities’ attitudes and requirements are employed for the correct pathway of pharmaceutical needs and have a great influence on the drug development process and had success through it. The role of Regulatory affairs professionals deals with all these aspects to get a desired result of drug development. The health authorities are framed to guide and analyse the drug which fulfils the appropriate quality and efficacy.

Top

Keywords

Pharmaceutical process, drug development, drug approval, role of regulatory affairs.

Top

  
║ Site map ║ Privacy Policy ║ Copyright ║ Terms & Conditions ║ Page Rank Tool
429,684,713 visitor(s) since 30th May, 2005.
All rights reserved. Site designed and maintained by DIVA ENTERPRISES PVT. LTD..
Note: Please use Internet Explorer (6.0 or above). Some functionalities may not work in other browsers.